SPE Capital and Proparco Exit Morocco’s Amanys Pharma
Source(s): SPE Capital
SPE Capital and Proparco fully exited Amanys Pharma, a Morocco-based manufacturer of antibiotics and hospital specialty drugs, via a strategic sale to Laprophan.
Source(s): SPE Capital
SPE Capital and Proparco fully exited Amanys Pharma, a Morocco-based manufacturer of antibiotics and hospital specialty drugs, via a strategic sale to Laprophan.